classified the SLFN11 immunohistochemical staining profiles into three groups, 1+ (1%–10%), 2+ (11%–50%), and 3+ (51%–100%), for semiquantitative evaluation of SLFN11 expression across a wide variety of sections of normal and tumor tissues (16). Here, SLFN11 is linked to neoplasm.